Daiichi may initiate legal action against former Ranbaxy shareholders2 min read . Updated: 23 May 2013, 09:36 AM IST
Daiichi says former shareholders concealed, misrepresented critical information on US investigations
Mumbai/New Delhi: Daiichi Sankyo Co. Ltd, the Japanese parent of Ranbaxy Laboratories Ltd, said on Wednesday that it may initiate legal action against certain former shareholders of the Indian generic drug maker for concealing and misrepresenting critical information related to investigations by US agencies.
Select your Category